Title

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)

UMMS Affiliation

Department of Medicine

Publication Date

2022-03-01

Document Type

Article

Disciplines

Health Services Administration | Health Services Research | Infectious Disease | Therapeutics | Virus Diseases

Abstract

This is an update of the American College of Physicians' living, rapid practice points on the use of remdesivir for treatment of COVID-19. This update is based on an updated living, rapid systematic review that included studies published through 19 October 2021 and identified 2 new studies meeting inclusion criteria.

Keywords

remdesivir, COVID-19

DOI of Published Version

10.7326/M21-4810

Source

Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Forciea MA, Miller MC, Humphrey LL; Scientific Medical Policy Committee of the American College of Physicians*. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3). Ann Intern Med. 2022 Mar 1. doi: 10.7326/M21-4810. Epub ahead of print. PMID: 35226518. Link to article on publisher's site

Journal/Book/Conference Title

Annals of internal medicine

Related Resources

Link to Article in PubMed

PubMed ID

35226518

Share

COinS